Filing Details
- Accession Number:
- 0000950170-23-058314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-02 16:49:54
- Reporting Period:
- 2023-11-01
- Accepted Time:
- 2023-11-02 16:49:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819133 | Tango Therapeutics Inc. | TNGX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1825445 | Adam Crystal | C/O Tango Therapeutics, Inc., 201 Brookline Ave., Suite 901 Boston MA 02215 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-01 | 7,507 | $8.39 | 81,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 7,507 shares that were acquired on October 31, 2023 pursuant to the Tango Therapeutics, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Billionaire Hedge Funds
